LifeStance Health Group, Inc. announced strong first quarter 2025 results, with revenue increasing 11% to $333.0 million and achieving a net income of $0.7 million, a significant improvement from a net loss in the prior year. The company also saw a 10% increase in its clinician base and visit volumes, contributing to its financial performance.
Revenue increased 11% to $333.0 million compared to $300.4 million in Q1 2024.
Net income reached $0.7 million, a substantial improvement from a net loss of $21.1 million in the prior year.
The clinician base grew 10% to 7,535 clinicians, with visit volumes also increasing 10% to 2.1 million.
Adjusted EBITDA increased 25% to $34.6 million, or 10.4% of total revenue, driven by higher revenue per visit and lower center costs.
LifeStance reiterated its full-year 2025 guidance and provided outlook for the second quarter of 2025, expecting continued growth in revenue, Center Margin, and Adjusted EBITDA.
Analyze how earnings announcements historically affect stock price performance